05:42 EST Cargo Therapeutics (CRGX) sinks 75% to $3.23 after study failure, analyst downgrades
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRGX:
- Cargo Therapeutics downgraded to Market Perform from Outperform at William Blair
- Cargo Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Cargo Therapeutics downgraded to Hold from Buy at Jefferies
- Cargo Therapeutics downgraded to Neutral from Buy at Chardan
- Cargo Therapeutics to discontinue FIRCE-1 Phase 2 study of Firi-cel
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue